NA Proactive news snapshot: O3 Mining, Vuzix Corporation, Todos Medical, Tetra Bio-Pharma ...

O3 Mining Inc (CVE:OIII) has hailed the results of a summer sampling program at its Alpha property in Val D’Or, in Québec, which combined with artificial intelligence (AI) modelling, has confirmed four strong drill targets for a potential discovery. The explorer said the findings would aid targeting in its current 100,000 metre (m) drilling campaign which began in September this year and is expected to be completed by April 2021.The summer work program comprised 31 outcrops and 4,650 channel samples and focused on the East Alpha area, where the Simkar, El Sol, and Goldora zones (Sector 3) and the Valdora, Sabourin, and Jolin zones (Sector 2) were tested. Highlighted assays include 128 grams per ton (g/t) gold over 0.7m at El Sol and 70.9 g/t of gold over 1.5 metres at Valdora. Vuzix Corporation (NASDAQ:VUZI) (FRA:V7XN), a leading supplier of smart glasses and Augmented Reality technology, revealed on Tuesday that it had expanded availability and upgraded support of its Zoom (including Zoom for Healthcare), Skype for Business and Webex Teams connector applications, now accessible on both its M4000 and M400 Smart Glasses. The Rochester, New York-based company said the releases of Zoom, Skype for Business and Webex Teams connector applications created by Vuzix over the past year have been well received by its customer base. “Thousands of Vuzix Smart Glasses devices in the field are currently using Vuzix' connector applications to support business continuity and operations across a variety of market verticals spanning healthcare, field service, audit and inspection and manufacturing,” said the company. Todos Medical Ltd (OTCQB:TOMDF) reported $3.2 million in sales for November 2020, up 269% from October 2020, following a strong final two weeks that saw the receipt of purchase orders for reagents to support increased testing demand due to the Thanksgiving holidays, as well as the completion of the Tecan liquid handler automation installation at Todos’ Wisconsin COVID-19 testing lab client. The company noted that it was cashflow positive in November 2020 for its COVID-19 testing business, and it has secured $2 million in traditional receivables financing to preserve its liquidity while it awaits client payments. Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) announced Wednesday that it has completed toxicology studies on its novel drug candidate ARDS-003, clearing the path for human clinical trials. Derived from cannabinoids, ARDS-003 is designed to prevent and treat acute respiratory distress syndrome (ARDS), a severe inflammatory response that could be life-threatening to patients with coronavirus (COVID-19) or sepsis. Tetra’s program included general toxicology studies in two species as well as specific studies to assess toxicity in major organ systems as well as genotoxicity. Empower Clinics Inc (CSE:CBDT) (OTCQB:EPWCF) (FRA:8EC), an integrated healthcare company, said on Wednesday that KAI Medical Laboratory will be launching a US Food and Drug Administration-approved, at home and work saliva-based COVID-19 reverse transcription PCR, or RT-PCR test on December 15. In addition, KAI’s ABC-PCR test protocol will simultaneously differentiate between Influenza A/B and COVID-19. In fact, the group’s previously announced major contract for testing in the film and TV industry will switch to Kai-handled ABC-PCR tests and launch on December 7. Empower said the deal represents a significantly higher purchase order of 10,000 tests.  Pacton Gold Inc (CVE:PAC) (OTCPINK:PACXF) (FRA:2NKM) said experienced mining industry executive Nav Dhaliwal has become the gold explorer's interim chief executive and president, reflecting the company’s greater focus on its two Red Lake, Ontario projects.  Outgoing interim CEO and president Alec Pismiris will remain as a director of Pacton, the firm said. Dhaliwal is a high-profile mining executive, financier, and capital markets expert, with a record of value creation. He was the founding chief executive of Bonterra Resources Inc (CVE:BTR) (OTCMKTS:BONXF) (FRA:9BR2), which made the award-winning Gladiator discovery in Quebec, and where he raised more than C$140 million and played a key role in growing the company's market cap to over C$200 million from C$10 million during the base of the gold market cycle. Bragg Gaming Group Inc (CVE:BRAG) (OTCMKTS:BRGGF) said its ORYX Gaming division will be sponsoring this year’s virtual edition of the prestigious World Gaming Executive Summit (WGES). The event, which will take place online on December 8 and December 9, 2020, is considered one of Europe’s most exclusive iGaming conferences and features panel debates, roundtables, presentations and networking events involving industry executives globally.  NexTech AR Solutions Corp (OTCQB:NEXCF) (CSE:NTAR) (FRA:N29) announced Wednesday the creation of a new artificial intelligence (AI) division intended to complement its augmented reality offerings. An initial team of three industry experts are focused on enhancing the company’s AI capabilities to gain a competitive edge and create new portfolio offerings for clients, the company said. Nova Royalty Corp (CVE:NOVR) (OTCMKTS:NVARF), the copper and nickel focused royalty group, updated Wednesday on First Quantum Minerals' (TSE:TM) (OTCMKTS:FQVLF) (FRA:IZ1) Taca Taca project in Argentina, where the former has just completed the acquisition of an existing 0.24% net smelter return (NSR) royalty. Significantly, the mining major, on November 30 this year, reported a maiden proven and probable reserve at Taca Taca of 7.7 million tonnes of copper metal. The company also updated the higher confidence measured and indicated (M&I) resource on the asset to 9.45 million tonnes of copper, an initial mine life of 32 years, and a timetable to consider a production decision in 2023 to 2024. Brain Scientific Inc (OTCQB:BRSF) announced Wednesday that it has filed a provisional US patent application for a new, long-term monitoring EEG cap. “The new EEG product for which Brain Scientific is seeking a patent approval is a flexible head cap for conducting electroencephalography,” said Irina Nazarova, the company’s marketing director, in a statement. “The cap carries multiple dry electrodes that are placed at various positions corresponding to various channels for bio-signal collection." Brain Scientific said the new flexible full head EEG cap is a response to the market demand for size-adjustable EEG, with maximized electrode placement coverage and strong contact with the scalp, where the person’s comfort is maximized and bio-signals collected are of high quality. Codebase Ventures Inc (CSE:CODE) (FRA:C5B) (OTCQB:BKLLF) announced Wednesday that its portfolio holding Arcology, a cluster-computing powered artificial intelligence (AI) blockchain company, has updated its working roadmap in response to its positive Testnet 1.0 results. “Building on Arcology Testnet 1.0, where we demonstrated compatibility with Ethereum, achieved our internal scalability targets and improved the user experience, we have updated our working roadmap to advance the technology,” said CEO Laurent Zhang in a statement. CytoDyn Inc (OTCQB:CYDY) announced Wednesday that the first patient has been enrolled for its Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis (NASH) with Vyrologix (leronlimab-PRO 140). The Phase 2 trial is designed to test whether leronlimab may inhibit the devastating liver fibrosis associated with NASH. As previously reported, the company’s pre-clinical study demonstrated strong positive data highlighting the potential of leronlimab in treating non-alcoholic fatty liver disease (NAFLD), a common precursor to NASH. It said the inhibition of CCR5 has been shown to be effective in reducing fibrosis in animal models of NASH liver fibrosis.  Great Bear Resources Ltd (CVE:GBR) said the TSX Venture Exchange has accepted for filing an option agreement dated October 16, 2020, between the company, 1544230 Ontario Inc., Gravel Ridge Resources Ltd. and Perry English, whereby Great Bear may acquire a 100% right, title and interest in and to the Red Lake North claims, located in the Red Lake gold district in Ontario. The consideration is 10,000 common shares and $125,000 in cash payments staged over a three-year period. Eurolife Brands Inc (CVE:EURO) confirmed that it has changed its name and symbol to Plant & Co. Brands Ltd. and VEGN, respectively. Shares will begin trading under the new name and symbol and with a new Cusip number on December 4, 2020. Eurolife Brands also announced separately that subject to the approval of the Canadian Securities Exchange, it proposes to issue up to 16 million units at a price of 20 cents per unit through a non-brokered private placement to raise up to $3.2 million in gross proceeds. Each unit will consist of one common share and one transferable common share purchase warrant, with each warrant exercisable into shares of the company at a price of 25 cents per share for two years from the date of closing of the private placement. The company intends to use the net proceeds from the private placement for merger and acquisition activities and opportunities and general working capital. All securities issued will be subject to a four-month hold period pursuant to securities laws in Canada. Finders' fees may be payable to qualified parties. Medexus Pharmaceuticals Inc. (CVE:MDP) (OTCQX:MEDXF) has announced that Ken d'Entremont, its chief executive officer and Roland Boivin, chief financial officer of Medexus, will present live at VirtualInvestorConferences.com on December 3, 2020, at 9.30am ET. This will be a live interactive online event where investors are invited to ask the company questions in real-time after registering using the following link: https://bit.ly/33ggdsmIf. For attendees who are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at www.virtualinvestorconferences.com. OTC Markets Group Inc. (OTCQX:OTCM), the operator of financial markets for over 11,000 U.S. and global securities, announced that Skylight Health Group. (CSE:SHG) (OTCQX:CBIIF), a healthcare services and technology company, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTCQBVenture Market. The OTCQX Market is designed for established, investor-focused US and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. "Graduating to the OTCQX Market is yet another milestone achieved as we continue to execute our focused growth plan of becoming one of the largest US integrated healthcare systems," said Prad Sekar, CEO of Skylight Health. "Having our shares traded on the top-tier of the OTC Markets in the US is a testament to Skylight's successful transition from a venture company to a fast-growing US healthcare company. Graduating today to the OTCQX is a welcome progression offering our shareholders increased cross-border liquidity as well as further increasing our visibility and shareholder exposure in the United States."